Advertisement

Surgical Strategy in Tricuspid Valve Endocarditis

  • Horatiu Moldovan
  • Adrian Molnar
  • Victor Costache
  • Ecaterina Bontaş
Chapter

Abstract

Until recent years, the infective endocarditis of the right heart was considered extremely rare. In the last 20 years the incidence of this disease is increasing, especially for the isolated tricuspid valve infective endocarditis. Most frequent causes are: drug abuse, uterine infections, cardiac implantable electronic devices like pacemakers/defibrillators leads, other intracardiac devices or cardiac malformations. Medical treatment with antibiotics is the mainstay option but surgery is often required for a group of patients. Surgical interventions include valvectomy (total excision of the tricuspid valve without substitution), reconstruction or valve replacement. Surgical strategy in tricuspid valve endocarditis can produce satisfactory results. The clear indication and timing of surgery remain debatable. Association with intravenous antibiotics is of paramount importance. Conservative techniques are the first choice but replacement remains an option when repair is not feasible. However, there is no clear evidence supporting one technique over another.

Keywords

Endocarditis Tricuspid valve Tricuspid valve repair Tricuspid valve re-placement Right heart endocarditis Intravenous drug abuser endocarditis Intracardiac electronic devices endocarditis 

References

  1. 1.
    Yong MS, Coffey S, Prendergast BD, Marasco SF, Zimmet AD, McGiffin DC, Saxena P. Surgical management of tricuspid valve endocarditis in the current era: a review. Int J Cardiol. 2016;202:44–8.  https://doi.org/10.1016/j.ijcard.2015.08.211.CrossRefPubMedGoogle Scholar
  2. 2.
    Cotrufo M, Carozza A, Romano G, De Feo M, Della Corte A. Infective endocarditis of native cardiac valves: 22 years’ surgical experience. J Heart Valve Dis. 2001;10:478–85.PubMedGoogle Scholar
  3. 3.
    Yamashita S, Noma K, Kuwata G, Miyoshi K, Honaga K. Infective endocarditis at the tricuspid valve following central venous catheterization. J Anesth. 2005;19(1):84–7.  https://doi.org/10.1007/s00540-004-0284-y.CrossRefPubMedGoogle Scholar
  4. 4.
    Popescu GA, Prazuck T, Poisson D, Picu C. A “true” polymicrobial endocarditis: Candida tropicalis and Staphylococcus aureus—to a drug user. Case presentation and literature review. Rom J Intern Med. 2005;43:157–61.PubMedGoogle Scholar
  5. 5.
    Kale SB, Raghavan J. Tricuspid valve endocarditis following central venous cannulation: the increasing problem of catheter related infection. Indian J Anaesth. 2013;57:390–3.  https://doi.org/10.4103/0019-5049.118564.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Carozza A, De Santo LS, Romano G, Della Corte A, Ursomando F, Scardone M, Caianiello G, Cotrufo M. Infective endocarditis in intravenous drug abusers: patterns of presentation and long-term outcomes of surgical treatment. J Heart Valve Dis. 2006;15:125–31.PubMedGoogle Scholar
  7. 7.
    Dupont P, Maragnes P, de la Gastine G, Jokic M, Morin M. Tricuspid valve endocarditis after umbilical piercing. Arch Mal Coeur Vaiss. 2006;99:629–31.PubMedGoogle Scholar
  8. 8.
    Rataj O, Martinkovičová L, Šetina M. Tricuspid valve infective endocarditis in intravenous drug abuser. Vnitr Lek. 2013;59:939–42.PubMedGoogle Scholar
  9. 9.
    Pachirat O, Chetchotisakd P, Klungboonkrong V, Taweesangsuksakul P, Tantisirin C, Loapiboon M. Infective endocarditis: prevalence, characteristics and mortality in Khon Kaen, 1990–1999. J Med Assoc Thail. 2002;85:1–10.Google Scholar
  10. 10.
    Unic D, Planinc M, Baric D, Rudez I, Blazekovic R, Senjug P, Sutlic Z. Isolated tricuspid valve libman-sacks endocarditis in systemic lupus erythematosus with secondary antiphospholipid syndrome. Tex Heart Inst J. 2017;44:147–9.  https://doi.org/10.14503/THIJ-16-5856.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Bai Z, Hou J, Ren W, Guo Y. Diagnosis and surgical treatment for isolated tricuspid Libman-Sacks endocarditis: a rare case report and literatures review. J Cardiothorac Surg. 2015;10:93.  https://doi.org/10.1186/s13019-015-0302-1.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Akinosoglou K, Apostolakis E, Koutsogiannis N, Leivaditis V, Gogos CA. Right-sided infective endocarditis: surgical management. Eur J Cardiothorac Surg. 2012;42:470–9.  https://doi.org/10.1093/ejcts/ezs084.CrossRefPubMedGoogle Scholar
  13. 13.
    Jassal DS, Hassan A, Buth KJ, Neilan TG, Koilpillai C, Hirsch GM. Surgical management of infective endocarditis. J Heart Valve Dis. 2006 Jan;15(1):115–21.PubMedGoogle Scholar
  14. 14.
    Kolek M, Brát R. Surgical treatment of infective endocarditis: 8 year experience. Cas Lek Cesk. 2006;145:718–24. discussion 724–5.PubMedGoogle Scholar
  15. 15.
    Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, Moreillon P, de Jesus Antunes M, Thilen U, Lekakis J, Lengyel M, Müller L, Naber CK, Nihoyannopoulos P, Moritz A, Zamorano JL, ESC Committee for Practice Guidelines. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009;30:2369–413.  https://doi.org/10.1093/eurheartj/ehp285.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O'Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD, ACC/AHA Task Force Members. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129:2440–92.  https://doi.org/10.1161/CIR.0000000000000029.CrossRefPubMedGoogle Scholar
  17. 17.
    Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Fleisher LA, Jneid H, Mack MJ, McLeod CJ, O'Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135:e1159–95.  https://doi.org/10.1161/CIR.0000000000000503.CrossRefPubMedGoogle Scholar
  18. 18.
    Denk K, Vahl CF. Infective endocarditis: considerations regarding optimal timing for surgical treatment. Herz. 2009;34:198–205.  https://doi.org/10.1007/s00059-009-3232-7.CrossRefPubMedGoogle Scholar
  19. 19.
    Poliakov VP, Shorokhov SE, Belyĭ VS, Goriachev VV, Kaganov II, Lias MN, Skuratova MA, Korytchenko VI, Suslina EA, Khokhlunov SM, Semagin AP. Surgical treatment of infective endocarditis of the right sections of the heart. Vestn Khir Im I I Grek. 2002;161:11–4.PubMedGoogle Scholar
  20. 20.
    Arbulu A, Holmes RJ, Asfaw I. Surgical treatment of intractable right-sided infective endocarditis in drug addicts: 25 years experience. J Heart Valve Dis. 1993;2:129–37. discussion 138–9.PubMedGoogle Scholar
  21. 21.
    Capoun R, Thomas M, Caputo M, Asimakopoulos G. Surgical treatment of tricuspid valve endocarditis: a single-centre experience. Perfusion. 2010;25:169–73.  https://doi.org/10.1177/0267659110371857.CrossRefPubMedGoogle Scholar
  22. 22.
    García-Rinaldi R. Tricuspid anterior leaflet replacement with autologous pericardium and polytetrafluoroethylene chordae, followed by edge-to-edge repair. Tex Heart Inst J. 2007;34:310–2.PubMedPubMedCentralGoogle Scholar
  23. 23.
    Pomar JL, Mestres CA, Pare JC, Miro JM. Management of persistent tricuspid endocarditis with transplantation of cryopreserved mitral homografts. J Thorac Cardiovasc Surg. 1994;107:1460–3.PubMedGoogle Scholar
  24. 24.
    Tarola CL, Losenno KL, Chu MW. Complex tricuspid valve repair for infective endocarditis: leaflet augmentation, chordae and annular reconstruction. Multimed Man Cardiothorac Surg. 2015.  https://doi.org/10.1093/mmcts/mmv006.
  25. 25.
    Sugimoto T, Okada M, Yamashita C, Ataka K, Yoshida M, Toyoda Y, Ozaki N. Surgical assessment of tricuspid valve replacement for severe tricuspid regurgitation without stenosis. Ann Thorac Cardiovasc Surg. 1999;5:300–3.PubMedGoogle Scholar
  26. 26.
    Gaca JG, Sheng S, Daneshmand M, Rankin JS, Williams ML, O'Brien SM, Gammie JS. Current outcomes for tricuspid valve infective endocarditis surgery in North America. Ann Thorac Surg. 2013;96:1374–81.  https://doi.org/10.1016/j.athoracsur.2013.05.046.CrossRefPubMedGoogle Scholar
  27. 27.
    Gottardi R, Bialy J, Devyatko E, Tschernich H, Czerny M, Wolner E, Seitelberger R. Midterm follow-up of tricuspid valve reconstruction due to active infective endocarditis. Ann Thorac Surg. 2007;84:1943–8.  https://doi.org/10.1016/j.athoracsur.2007.04.116.CrossRefPubMedGoogle Scholar
  28. 28.
    André C, Da Silva MM, Da Silva EJ, Souza MA, Bastos ES, Novis SA. Postoperative mortality in infective endocarditis: determinant factors. Arq Neuropsiquiatr. 1997;55:231–6.CrossRefPubMedGoogle Scholar
  29. 29.
    Zhang L, Gao CQ, Jiang SL, Ren CL. Surgical treatment of isolated right-sided infective endocarditis. Zhonghua Wai Ke Za Zhi. 2010;48:342–4.PubMedGoogle Scholar
  30. 30.
    Chen Q, Cao H, Lu H, Qiu ZH, He JJ. Bioprosthetic tricuspid valve endocarditis caused by Acinetobacter baumannii complex, a case report and brief review of the literature. J Cardiothorac Surg. 2015;10:149.  https://doi.org/10.1186/s13019-015-0377-8.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Fayad G, Modine T, Lions C, Polge AS, Azzaoui R, Larrue B, Decoene C, Leroy O, Senneville E, Beregi JP, Warembourg H. Conservative surgical treatment for active infective tricuspid valve endocarditis according to the “clover technique”. Heart Surg Forum. 2008;11:E120–6.  https://doi.org/10.1532/HSF98.20071188.CrossRefPubMedGoogle Scholar
  32. 32.
    Gutierrez-Martin MA, Galvez-Aceval J, Araji OA. Indications for surgery and operative techniques in infective endocarditis in the present day. Infect Disord Drug Targets. 2010;10:32–46.CrossRefPubMedGoogle Scholar
  33. 33.
    Jiang SL, Li BJ, Zhang T, Ren CL, Wang Y, Chen TT, Gao CQ. Surgical treatment of isolated right-sided infective endocarditis. Tex Heart Inst J. 2011;38:639–42.PubMedPubMedCentralGoogle Scholar
  34. 34.
    Musci M, Siniawski H, Pasic M, Grauhan O, Weng Y, Meyer R, Yankah CA, Hetzer R. Surgical treatment of right-sided active infective endocarditis with or without involvement of the left heart: 20-year single center experience. Eur J Cardiothorac Surg. 2007;32:118–25.  https://doi.org/10.1016/j.ejcts.2007.02.034.CrossRefPubMedGoogle Scholar
  35. 35.
    Myerson M, Armstrong EJ, Poltavskiy E, Fefer J, Bang H. Tricuspid valve replacement in an HIV-infected patient with severe tricuspid regurgitation secondary to remote endocarditis. Tex Heart Inst J. 2016;43:514–6.  https://doi.org/10.14503/THIJ-15-5354.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Margey R, McCann H, Blake G, Keelan E, Galvin J, Lynch M, Mahon N, Sugrue D, O'Neill J. Contemporary management of and outcomes from cardiac device related infections. Europace. 2010;12:64–70.  https://doi.org/10.1093/europace/eup362.CrossRefPubMedGoogle Scholar
  37. 37.
    Shetty N, Nagpal D, Koivu S, Mrkobrada M. Surgical and medical management of isolated tricuspid valve infective endocarditis in intravenous drug users. J Card Surg. 2016;31:83–8.  https://doi.org/10.1111/jocs.12682.CrossRefPubMedGoogle Scholar
  38. 38.
    Baddour LM, Epstein AE, Erickson CC, Knight BP, Levison ME, Lockhart PB, Masoudi FA, Okum EJ, Wilson WR, Beerman LB, Bolger AF, Estes NA 3rd, Gewitz M, Newburger JW, Schron EB, Taubert KA, American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee; Council on Cardiovascular Disease in Young; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Nursing; Council on Clinical Cardiology; Interdisciplinary Council on Quality of Care; American Heart Association. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010;121:458–77.  https://doi.org/10.1161/CIRCULATIONAHA.109.CrossRefPubMedGoogle Scholar
  39. 39.
    Pang PY, Sin YK, Lim CH, Tan TE, Lim SL, Chao VT, Chua YL. Surgical management of infective endocarditis: an analysis of early and late outcomes. Eur J Cardiothorac Surg. 2015;47:826–32.  https://doi.org/10.1093/ejcts/ezu281.CrossRefPubMedGoogle Scholar
  40. 40.
    Chambers J, Sandoe J, Ray S, Prendergast B, Taggart D, Westaby S, Arden C, Grothier L, Wilson J, Campbell B, Gohlke-Bärwolf C, Mestres CA, Rosenhek R, Pibarot P, Otto C. The infective endocarditis team: recommendations from an international working group. Heart. 2014;100(7):524.  https://doi.org/10.1136/heartjnl-2013-304354.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Horatiu Moldovan
    • 1
    • 2
    • 3
    • 4
  • Adrian Molnar
    • 5
    • 6
  • Victor Costache
    • 7
  • Ecaterina Bontaş
    • 8
  1. 1.Department of Cardiovascular SurgeryTitu Maiorescu UniversityBucharestRomania
  2. 2.Department of Cardiovascular Biomaterials, Department of Science and Engineering in BiomaterialsPolitehnica University of Bucharest (UPB)BucharestRomania
  3. 3.Romanian Academy of Medical SciencesBucharestRomania
  4. 4.Department of Cardiovascular SurgerySanador Clinical HospitalBucharestRomania
  5. 5.Department of Cardiovascular SurgeryUniversity of Medicine and PharmacyCluj-NapocaRomania
  6. 6.Department of Cardiovascular SurgeryHeart Institute “Niculae Stancioiu”Cluj-NapocaRomania
  7. 7.Department of Cardiovascular and Thoracic SurgeryPOLISANO HospitalSibiuRomania
  8. 8.Department of Cardiology“Prof. C.C. Iliescu” Emergency Institute for Cardiovascular Diseases BucharestBucharestRomania

Personalised recommendations